StockData
Takeda Pharmaceutical Co Ltd logo

Takeda Pharmaceutical Co Ltd (TKPHF) revenue by segment

TKPHFOTCPharmaceutical PreparationsAlso trades as TAK
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30
$39.00+0.36 (+0.93%)

Close on Oct 19, 2026Market cap $134.41BP/E –Yield –

Takeda Pharmaceutical Co Ltd revenue by segment

No segment breakdown reported

Takeda Pharmaceutical does not break out revenue by segment, region or product in the tagged data of its filings for this period type.